1. Home
  2. ZYME vs BLBD Comparison

ZYME vs BLBD Comparison

Compare ZYME & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$28.10

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$57.26

Market Cap

1.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
BLBD
Founded
2003
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
ZYME
BLBD
Price
$28.10
$57.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
8
Target Price
$41.21
★ $89.13
AVG Volume (30 Days)
★ 869.8K
455.5K
Earning Date
11-09-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.33
22.78
EPS
N/A
★ 7.33
Revenue
$105,965,000.00
★ $1,480,099,000.00
Revenue This Year
$173.22
$18.37
Revenue Next Year
$35.07
$14.95
P/E Ratio
★ N/A
$7.80
Revenue Growth
★ 38.87
9.87
52 Week Low
$16.00
$46.14
52 Week High
$31.34
$83.39

Technical Indicators

Market Signals
Indicator
ZYME
BLBD
Relative Strength Index (RSI) 59.63 47.27
Support Level $22.04 $54.90
Resistance Level $29.75 $57.72
Average True Range (ATR) 1.05 1.61
MACD 0.21 0.38
Stochastic Oscillator 96.19 59.74

Price Performance

Historical Comparison
ZYME
BLBD

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: